Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hazel M Dockrell

Showing results (11-20 of 160) with videos related to

Pageof 16
Sort By:
Ebiomedicine|April 15, 2022
Tuberculosis vaccines in the era of Covid-19 - what is taking us so long?Hazel M Dockrell, Helen McShane
American Journal of Respiratory and Critical Care Medicine|April 9, 2009
A courageous step down the road toward a new tuberculosis vaccineHazel M Dockrell, Ying Zhang
Vaccine|February 15, 2021
Can what have we learnt about BCG vaccination in the last 20 years help us to design a better tuberculosis vaccine?Hazel M Dockrell, Egle Butkeviciute
The Lancet. Diabetes & Endocrinology|April 8, 2014
TANDEM: understanding diabetes and tuberculosisReinout van Crevel, Hazel M Dockrell,
Frontiers in Immunology|September 29, 2017
What Have We Learnt about BCG Vaccination in the Last 20 Years?Hazel M Dockrell, Steven G Smith
Future Microbiology|May 21, 2016
Human biomarkers: can they help us to develop a new tuberculosis vaccine?Helen A Fletcher, Hazel M Dockrell
Leprosy Review|March 12, 2009
Global collaborations in leprosy research--the future is connectedHazel M Dockrell, Linda Oskam, Jan Hendrik Richardus
Current Opinion in Infectious Diseases|June 25, 2003
Dynamics of cytokine generation in patients with active pulmonary tuberculosisEun-Kyeong Jo, Jeong-Kyu Park, Hazel M Dockrell
Expert Review of Vaccines|February 8, 2012
Variability between countries in cytokine responses to BCG vaccination: what impact might this have on protection?Hazel M Dockrell, Steven G Smith, Maeve K Lalor
Tuberculosis (Edinburgh, Scotland)|December 6, 2018
Meeting report: 5th Global Forum on TB Vaccines, 20-23 February 2018, New Delhi IndiaKrishnamohan Atmakuri, Adam Penn-Nicholson, Rachel Tanner, et al.
Pageof 16

Showing results (11-20 of 160) with videos related to

Sort By:
Pageof 16
Ebiomedicine|April 15, 2022
Tuberculosis vaccines in the era of Covid-19 - what is taking us so long?Hazel M Dockrell, Helen McShane
American Journal of Respiratory and Critical Care Medicine|April 9, 2009
A courageous step down the road toward a new tuberculosis vaccineHazel M Dockrell, Ying Zhang
Vaccine|February 15, 2021
Can what have we learnt about BCG vaccination in the last 20 years help us to design a better tuberculosis vaccine?Hazel M Dockrell, Egle Butkeviciute
The Lancet. Diabetes & Endocrinology|April 8, 2014
TANDEM: understanding diabetes and tuberculosisReinout van Crevel, Hazel M Dockrell,
Frontiers in Immunology|September 29, 2017
What Have We Learnt about BCG Vaccination in the Last 20 Years?Hazel M Dockrell, Steven G Smith
Future Microbiology|May 21, 2016
Human biomarkers: can they help us to develop a new tuberculosis vaccine?Helen A Fletcher, Hazel M Dockrell
Leprosy Review|March 12, 2009
Global collaborations in leprosy research--the future is connectedHazel M Dockrell, Linda Oskam, Jan Hendrik Richardus
Current Opinion in Infectious Diseases|June 25, 2003
Dynamics of cytokine generation in patients with active pulmonary tuberculosisEun-Kyeong Jo, Jeong-Kyu Park, Hazel M Dockrell
Expert Review of Vaccines|February 8, 2012
Variability between countries in cytokine responses to BCG vaccination: what impact might this have on protection?Hazel M Dockrell, Steven G Smith, Maeve K Lalor
Tuberculosis (Edinburgh, Scotland)|December 6, 2018
Meeting report: 5th Global Forum on TB Vaccines, 20-23 February 2018, New Delhi IndiaKrishnamohan Atmakuri, Adam Penn-Nicholson, Rachel Tanner, et al.
Pageof 16